NCT03824860 Yoga for Painful Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized-Controlled Study Status COMPLETED Phase NA
NCT03789110 NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03783546 Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial Status COMPLETED Phase NA
NCT03782064 Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma Status TERMINATED Phase PHASE2
NCT03777982 Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT Status TERMINATED Phase PHASE3
NCT03777410 Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma Status TERMINATED Phase N/A
NCT03773666 A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2) Status COMPLETED Phase PHASE1
NCT03765983 GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases Status TERMINATED Phase PHASE2
NCT03762590 GENetic Education Risk Assessment and TEsting Study Status ACTIVE_NOT_RECRUITING Phase NA
NCT03761160 Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy Status COMPLETED Phase NA
NCT03749421 Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03740334 Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03736746 Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals Status COMPLETED Phase NA
NCT03735446 Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial Status TERMINATED Phase PHASE1
NCT03717480 Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies Status TERMINATED Phase PHASE2
NCT03716739 Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency Status COMPLETED Phase PHASE2